Get started
Clarity Pharmaceuticals Ltd.Clarity Pharmaceuticals Ltd.Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CLRPF chart


Full chart

CLRPF upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪723.65 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.13 USD
Net income (FY)
‪−42.28 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪260.94 M‬
Beta (1Y)
3.36

About Clarity Pharmaceuticals Ltd.


Sector
Health Technology
Industry
Medical Specialties
CEO
Michelle Parker
Website
claritypharmaceuticals.com
Headquarters
Eveleigh
Founded
2010
ISIN
AU0000165375
FIGI
BBG016LHSWM9
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.

Check out other big names from the same industry as CLRPF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CLRPF news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CLRPF is 1.95 USD — it has decreased by −7.14% in the past 24 hours. Watch Clarity Pharmaceuticals Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Clarity Pharmaceuticals Ltd. stocks are traded under the ticker CLRPF.
CLRPF stock has fallen by −16.67% compared to the previous week, the month change is a −31.58% fall, over the last year Clarity Pharmaceuticals Ltd. has showed a −56.88% decrease.
We've gathered analysts' opinions on Clarity Pharmaceuticals Ltd. future price: according to them, CLRPF price has a max estimate of 5.99 USD and a min estimate of 3.25 USD. Watch CLRPF chart and read a more detailed Clarity Pharmaceuticals Ltd. stock forecast: see what analysts think of Clarity Pharmaceuticals Ltd. and suggest that you do with its stocks.
CLRPF reached its all-time high on Sep 23, 2024 with the price of 6.40 USD, and its all-time low was 0.48 USD and was reached on Jun 26, 2023. View more price dynamics on CLRPF chart.
See other stocks reaching their highest and lowest prices.
CLRPF stock is 7.69% volatile and has beta coefficient of 3.36. Track Clarity Pharmaceuticals Ltd. stock price on the chart and check out the list of the most volatile stocks — is Clarity Pharmaceuticals Ltd. there?
Today Clarity Pharmaceuticals Ltd. has the market capitalization of ‪724.76 M‬, it has increased by 14.82% over the last week.
Yes, you can track Clarity Pharmaceuticals Ltd. financials in yearly and quarterly reports right on TradingView.
Clarity Pharmaceuticals Ltd. is going to release the next earnings report on Mar 4, 2026. Keep track of upcoming events with our Earnings Calendar.
CLRPF earnings for the last half-year are −0.08 USD per share, whereas the estimation was −0.05 USD, resulting in a −51.42% surprise. The estimated earnings for the next half-year are −0.08 USD per share. See more details about Clarity Pharmaceuticals Ltd. earnings.
Clarity Pharmaceuticals Ltd. revenue for the last half-year amounts to ‪3.14 M‬ USD, despite the estimated figure of ‪3.63 M‬ USD. In the next half-year revenue is expected to reach ‪3.12 M‬ USD.
CLRPF net income for the last half-year is ‪−26.77 M‬ USD, while the previous report showed ‪−14.59 M‬ USD of net income which accounts for −83.51% change. Track more Clarity Pharmaceuticals Ltd. financial stats to get the full picture.
No, CLRPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLRPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Clarity Pharmaceuticals Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Clarity Pharmaceuticals Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Clarity Pharmaceuticals Ltd. stock shows the sell signal. See more of Clarity Pharmaceuticals Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.